Market Value1,731,086,869
Total Holdings49
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IBRX / ImmunityBio, Inc. Put
SYRE / Spyre Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
MLTX / MoonLake Immunotherapeutics
CRBP / Corbus Pharmaceuticals Holdings, Inc.
EWTX / Edgewise Therapeutics, Inc.
AVBP / ArriVent BioPharma, Inc.
PRAX / Praxis Precision Medicines, Inc.
RAPT / RAPT Therapeutics, Inc.
ALMS / Alumis Inc.
LBPH / Longboard Pharmaceuticals, Inc.
IMRX / Immuneering Corporation
RAPP / Rapport Therapeutics, Inc.
URGN / UroGen Pharma Ltd.
RYTM / Rhythm Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
ACLX / Arcellx, Inc.
VYNE / VYNE Therapeutics Inc.
YMAB / Y-mAbs Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
BEAM / Beam Therapeutics Inc. Put
BCAB / BioAtla, Inc.
KYTX / Kyverna Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
NKTX / Nkarta, Inc.
IRON / Disc Medicine, Inc.
AVTE / Aerovate Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
CGON / CG Oncology, Inc.
NGNE / Neurogene Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
CMPX / Compass Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
MRSN / Mersana Therapeutics, Inc.
LNTH / Lantheus Holdings, Inc.
CGEM / Cullinan Therapeutics, Inc.
GHRS / GH Research PLC
KRRO / Korro Bio, Inc.
RNA / Avidity Biosciences, Inc.
CRGX / CARGO Therapeutics, Inc.
HLXB / Helix Acquisition Corp. II
PCVX / Vaxcyte, Inc.
BMEA / Biomea Fusion, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
BHVN / Biohaven Ltd.
CRNX / Crinetics Pharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
ENGN / enGene Holdings Inc.
JANX / Janux Therapeutics, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
MRUS / Merus N.V.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PHVS / Pharvaris N.V.
STOK / Stoke Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
INSM / Insmed Incorporated
AXSM / Axsome Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
SIGA / SIGA Technologies, Inc. Put
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.